Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 938443-19-7 | MDL No. : | MFCD12755863 |
Formula : | C7H4ClN3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DJHNDPHQSQMESD-UHFFFAOYSA-N |
M.W : | 197.58 | Pubchem ID : | 40152233 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.99 |
TPSA : | 78.61 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.03 cm/s |
Log Po/w (iLOGP) : | 0.94 |
Log Po/w (XLOGP3) : | 0.67 |
Log Po/w (WLOGP) : | 0.26 |
Log Po/w (MLOGP) : | 0.85 |
Log Po/w (SILICOS-IT) : | 2.36 |
Consensus Log Po/w : | 1.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.06 |
Solubility : | 1.74 mg/ml ; 0.00878 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.9 |
Solubility : | 2.5 mg/ml ; 0.0127 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.39 |
Solubility : | 0.0803 mg/ml ; 0.000406 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.77 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h; Stage #2: With trichlorophosphate In toluene at 20 - 100℃; for 2.5 h; |
d) 2,4, 7-Trichloro-pyrido[2,3-d]pyrimidine (Inter.5); To a stirred 0.5 M suspension of the dione (Inter. 4)(1 equiv.) in anhydrous toluene under an inert atmosphere was slowly added diisopropylethylamine (3 equiv.). The reaction mixture was then heated to 700C for 30 minutes and then cooled to room temperature prior to the addition of POCl3 (3 equivalents). The reaction was then heated to 100°C for 2.5 hours before being cooled and concentrated in vacuo to give a crude slurry which was then suspended in EtOAc and filtered through a thin pad of Celite.(TM).. The filtrate was concentrated in vacuo to give a brown, oil which was dissolved in CH2Cl2 and stirred over silica gel for 30 minutes. After this time the silica was removed by filtration, the filtrate concentrated and the crude residue purified by flash chromatography (SiO2) to give the title compound in analytically pure form (48percent yield, 96percent purity), m/z (LC-MS, ESP): 234 [M+H]+ R/T = 4.21 mins |
48% | Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h; Stage #2: With trichlorophosphate In toluene at 100℃; for 2.5 h; |
To a stirred 0.5 M suspension of the appropriate dione (1 equiv) in anhydrous toluene under an inert atmosphere was slowly added diisopropylethylamine (3 equiv). The reaction mixture was then heated to 70 0C for 30 minutes and then cooled to room temperature prior to the addition of POCl3 (3 equiv). The reaction was then heated to 100 0C for 2.5 hours before being cooled and concentrated in vacuo to give a crude slurry which was then suspended in EtOAc and filtered through a thin pad of Celite.(TM).. The filtrate was concentrated in vacuo to give a brown, oil which was dissolved in CH2Cl2 and stirred over silica gel for 30 minutes. After this time the silica was removed by filtration, the filtrate concentrated and the crude residue purified by flash chromatography (SiO2) to give the title compound in analytically pure form.2,4,7-Trichloro-ρyrido[2,3-d]pyrimidine- X=N, Y=C, Z=C: (48 percent yield, 96 percent purity) m/z (LC-MS, ESP): 234 [M+H]+ R/T = 4.21 min |
0.5 g | Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h; Stage #2: at 0 - 110℃; for 4 h; |
To the reaction bottle 7-chloro-pyrido [2,3-d] pyrimidine -2,4 (1H, 3H)-dione (1.98g, 10mmol), diisopropyl ethylamine (3.87g, 30mmol) and toluene, for 70 °C reaction 30 minutes, cooling dropping POCl 3 (4.59g, 30mmol), 110 °C reaction under 4h to the column product splines, 0.5g, the yield is 21.4percent. |
[ 21038-66-4 ]
Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.87
[ 204933-50-6 ]
2,3-Dihydropyrido[2,3-d]pyrimidin-4(1H)-one
Similarity: 0.82
[ 56783-85-8 ]
6-Aminopyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.82
[ 21038-66-4 ]
Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.87
[ 204933-50-6 ]
2,3-Dihydropyrido[2,3-d]pyrimidin-4(1H)-one
Similarity: 0.82
[ 56783-85-8 ]
6-Aminopyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Similarity: 0.82